These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 27797225)

  • 1. Circulating miR-195 as a Therapeutic Biomarker in Turkish Breast Cancer Patients.
    Cecene G; Ak S; Eskiler GG; Demirdogen E; Erturk E; Gokgoz S; Polatkan V; Egeli U; Tunca B; Tezcan G; Topal U; Tolunay S; Tasdelen I
    Asian Pac J Cancer Prev; 2016; 17(9):4241-4246. PubMed ID: 27797225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating microRNA-based screening tool for breast cancer.
    Frères P; Wenric S; Boukerroucha M; Fasquelle C; Thiry J; Bovy N; Struman I; Geurts P; Collignon J; Schroeder H; Kridelka F; Lifrange E; Jossa V; Bours V; Josse C; Jerusalem G
    Oncotarget; 2016 Feb; 7(5):5416-28. PubMed ID: 26734993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma microRNAs Predict Chemoresistance in Patients With Metastatic Breast Cancer.
    Shao B; Wang X; Zhang L; Li D; Liu X; Song G; Cao H; Zhu J; Li H
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819828709. PubMed ID: 30786836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA.
    Yie SM; Luo B; Ye NY; Xie K; Ye SR
    Clin Exp Metastasis; 2006; 23(5-6):279-89. PubMed ID: 17086357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.
    Li G; Yao L; Zhang J; Li X; Dang S; Zeng K; Zhou Y; Gao F
    Tumour Biol; 2016 Jun; 37(6):7481-91. PubMed ID: 26678891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
    Wang B; Li J; Sun M; Sun L; Zhang X
    IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating microRNAs in plasma as early detection markers for breast cancer.
    Cuk K; Zucknick M; Heil J; Madhavan D; Schott S; Turchinovich A; Arlt D; Rath M; Sohn C; Benner A; Junkermann H; Schneeweiss A; Burwinkel B
    Int J Cancer; 2013 Apr; 132(7):1602-12. PubMed ID: 22927033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of circulating tumor cells in breast cancer patients using multiplex reverse transcription-polymerase chain reaction and specific primers for MGB, PTHRP and KRT19 correlation with clinicopathological features.
    Skondra M; Gkioka E; Kostakis ID; Pissimissis N; Lembessis P; Pectasides D; Koutsilieris M
    Anticancer Res; 2014 Nov; 34(11):6691-9. PubMed ID: 25368276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients.
    Alunni-Fabbroni M; Majunke L; Trapp EK; Tzschaschel M; Mahner S; Fasching PA; Fehm T; Schneeweiss A; Beck T; Lorenz R; Friedl TWP; Janni W; Rack B;
    BMC Cancer; 2018 Feb; 18(1):141. PubMed ID: 29409452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating miR-34a and miR-125b as Promising non Invasive Biomarkers in Egyptian Locally Advanced Breast Cancer Patients.
    Kassem NM; Makar WS; Kassem HA; Talima S; Tarek M; Hesham H; El-Desouky MA
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2749-2755. PubMed ID: 31554373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in circulating miRNA levels following early-stage estrogen receptor-positive breast cancer resection in post-menopausal women.
    Kodahl AR; Zeuthen P; Binder H; Knoop AS; Ditzel HJ
    PLoS One; 2014; 9(7):e101950. PubMed ID: 25004125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of differential distribution of microvessel density, possibly regulated by miR-374a, on breast cancer prognosis.
    Li JY; Zhang Y; Zhang WH; Jia S; Kang Y; Tian R
    Asian Pac J Cancer Prev; 2013; 14(3):1715-20. PubMed ID: 23679262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue.
    Mar-Aguilar F; Luna-Aguirre CM; Moreno-Rocha JC; Araiza-Chávez J; Trevino V; Rodríguez-Padilla C; Reséndez-Pérez D
    Asia Pac J Clin Oncol; 2013 Mar; 9(1):53-9. PubMed ID: 22898264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum microRNA-21 expression as a prognostic and therapeutic biomarker for breast cancer patients.
    Yadav P; Mirza M; Nandi K; Jain SK; Kaza RC; Khurana N; Ray PC; Saxena A
    Tumour Biol; 2016 Nov; 37(11):15275-15282. PubMed ID: 27696295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients.
    Silva J; García V; García JM; Peña C; Domínguez G; Díaz R; Lorenzo Y; Hurtado A; Sánchez A; Bonilla F
    Breast Cancer Res; 2007; 9(4):R55. PubMed ID: 17711569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: potential biomarkers.
    Chen W; Cai F; Zhang B; Barekati Z; Zhong XY
    Tumour Biol; 2013 Feb; 34(1):455-62. PubMed ID: 23238818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
    Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
    Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential diagnostic role of circulating MiRNAs in breast cancer: Implications on clinicopathological characters.
    Swellam M; El Magdoub HM; Hassan NM; Hefny MM; Sobeih ME
    Clin Biochem; 2018 Jun; 56():47-54. PubMed ID: 29679553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-4728-3p could act as a marker of HER2 status.
    Li H; Zhou X; Zhu J; Cheng W; Zhu W; Shu Y; Liu P
    Cancer Biomark; 2015; 15(6):807-14. PubMed ID: 26406406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of serum miR-1915-3p and miR-455-3p as biomarkers for breast cancer.
    Guo J; Liu C; Wang W; Liu Y; He H; Chen C; Xiang R; Luo Y
    PLoS One; 2018; 13(7):e0200716. PubMed ID: 30048472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.